On December 15, Gelonghui Pharmaceutical (002566.SZ) announced that the company and its subsidiaries have received a total of RMB 10.356 million in government subsidies from February 21, 2023 to the date of disclosure of the announcement, including government subsidies of RMB 3.356 million relating to revenue and RMB 700,000 million in asset-related government subsidies.
益盛药业(002566.SZ)：累计收到政府补助1035.60万元
Yisheng Pharmaceutical (002566.SZ): Received a total of 10.356 million yuan in government subsidies
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.